The purpose of the Protein Microsequencing Shared Resource is to provide state-of-the-art methodology in protein sequencing and protein analysis. Protein sequencing is described as being a unique technology, requiring specific, dedicated, and specialized instrumentation. The staff includes the Core Leader, a technician, and two helpers. Sequencing is done on a Beckman-Porton Sequencer, using gas phase chemistry. The amino acid analyses are done using Pico-Tag chemistry. The protocols for in-gel and on-blot tryptic digestions were developed by the staff of the facility. Investigators can either use the protocols described on the facility?s homepage or the digestion and separation of the resulting peptide fragments on a reverse phase HPLC system. The peptides present in the HPLC fractions are analyzed on a sensitive MALDI mass spectrophotometer located in the UCLA Center for Mass Spectrometry. This instrument was acquired in 1994 as a joint effort of the Protein Microsequencing Shared Resource and the UCLA Center for Mass Spectrometry, with a major portion of the funding from the CCSG. The specific goals of the facility include providing: 1) state-of-the-art methodology in protein microsequencing to the UCLA research community; 2) sensitive amino acid analyses; 3) assistance and information to laboratory investigators about determination of protein structure; and 4) other protein services, including protein cleavages, mass analyses, and isolation of internal fragments by HPLC of gel methods. The operating policies of the facility include a determination of the priority of samples received for sequencing. The highest priority goes to members of the Cancer Center and to researchers in the Department of Biological Chemistry, which provides space for the facility, and then to other members of the UCLA community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016042-28
Application #
6563723
Study Section
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
28
Fiscal Year
2002
Total Cost
$167,178
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Waters, Lynnea R; Ahsan, Fasih M; Wolf, Dane M et al. (2018) Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience 5:99-109
Van Dyk, Kathleen; Bower, Julienne E; Crespi, Catherine M et al. (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25
Robinett, Ryan A; Guan, Ning; Lux, Anja et al. (2018) Dissecting Fc?R Regulation through a Multivalent Binding Model. Cell Syst 7:41-48.e5
Chin, Chee Jia; Li, Suwen; Corselli, Mirko et al. (2018) Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells. Stem Cell Reports 10:436-446
Alban, Tyler J; Alvarado, Alvaro G; Sorensen, Mia D et al. (2018) Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. JCI Insight 3:
Yang, Qing; Fung, Wing K; Li, Gang (2018) Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks. Stat Med 37:1389-1401
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987
Ribas, Antoni; Wolchok, Jedd D (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350-1355
Wang, Hong; Chen, Xiaolin; Li, Gang (2018) Survival Forests with R-Squared Splitting Rules. J Comput Biol 25:388-395

Showing the most recent 10 out of 767 publications